
Metffil G 0.5mg/500mg Tablet
Marketer
Fourrts India Laboratories Pvt Ltd
Salt Composition
Glimepiride (0.5mg) + Metformin (500mg)
Overview Metffil G 0.5mg/500mg Tablet
Diabetol Duo 0.5mg/500mg tablets are classified as antidiabetic medications, combining two active components to manage type 2 diabetes in adults. This dual-action formulation aids in regulating blood glucose levels. Diabetol Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical guidance can lead to elevated glucose levels, potentially resulting in kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Maintaining regular mealtimes and carrying a readily available fast-acting glucose source (e.g., sugary sweets or fruit juice) is vital for prevention. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician prior to commencing treatment. Its suitability for pregnant or lactating women should be assessed by their doctor. Regular blood glucose monitoring and periodic blood tests (including complete blood count and liver function tests) are recommended.
Uses of Metffil G 0.5mg/500mg Tablet
Managing type 2 diabetes
Major Benefits of Metffil G 0.5mg/500mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Metffil G 0.5mg/500mg Tablet should be administered with a meal.
Common Side effects of Metffil G 0.5mg/500mg Tablet:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Metffil G 0.5mg/500mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or dividing it. The Metffil G 0.5mg/500mg Tablet should be administered with a meal.
How Metffil G 0.5mg/500mg Tablet works:
Each Metffil G 0.5mg/500mg tablet contains glimepiride (a sulfonylurea) and metformin (a biguanide), two medications that manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin works through three mechanisms: decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metffil G 0.5mg/500mg tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Use of Metffil G 0.5mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingUNSAFE
Lactation and Metffil G 0.5mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Metffil G 0.5mg/500mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. This medication is contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should use Metffil G 0.5mg/500mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, Metffil G 0.5mg/500mg tablets are typically initiated at a low dose; however, their use is contraindicated in patients with severe liver dysfunction.
What if you forget to take Metffil G 0.5mg/500mg Tablet :
Should you forget a Metffil G 0.5mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Metffil G 0.5mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
